Specialty Insurance

Is Insurance Failing Patients With Parkinson’s Disease?
Insurance Is Insurance Failing Patients With Parkinson’s Disease?

The scientific consensus now dictates that the most effective way to slow the physiological progression of Parkinson’s disease is through immediate, high-intensity aerobic and resistance training, yet current American health insurance protocols remain stubbornly tethered to a reactive model of

Jury Sides With Cancer Patient Over Denied Treatment Coverage
Insurance Jury Sides With Cancer Patient Over Denied Treatment Coverage

A terminal diagnosis often forces families into a desperate race against time, but for Pablo Langesfeld, the struggle for survival has become a multi-front battle involving both a relentless disease and a rigid corporate bureaucracy. Having previously survived the catastrophic collapse of the

P&C Insurance Sector Faces Challenges Despite Strong Revenue
Insurance P&C Insurance Sector Faces Challenges Despite Strong Revenue

The current global financial landscape of early 2026 has placed Property and Casualty insurance providers in a unique position where their fundamental business models are being tested by a convergence of technological shifts and rising geopolitical tensions. As a fundamental pillar of the global

The Evolution of RWI in 2026 Transactional Negotiations
Insurance The Evolution of RWI in 2026 Transactional Negotiations

The landscape of mergers and acquisitions has reached a pivotal juncture where the absence of specific insurance coverage is no longer a viable option for most sophisticated dealmakers. Representation and Warranty Insurance has transitioned from an innovative risk-mitigation tool used primarily by

Can a New US Insurance Plan Stabilize the Strait of Hormuz?
Insurance Can a New US Insurance Plan Stabilize the Strait of Hormuz?

The sudden announcement of a multi-billion dollar federal reinsurance initiative has fundamentally altered the risk assessment landscape for global shipping companies operating within the volatile waters of the Middle East. Under the guidance of the U.S. Treasury Department and Secretary Scott

Can Life Sciences Leaders Manage D&O Volatility and Risks?
Insurance Can Life Sciences Leaders Manage D&O Volatility and Risks?

The modern life sciences landscape presents a striking paradox where the apparent calm of the broader insurance market masks a turbulent undercurrent of executive liability specific to pharmaceutical and medical technology firms. While general commercial lines might show signs of stabilization, the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later